Skip to content
Tagged COVID-19 Biotechnology SARS-CoV-2 Life Science cancer CORONAVIRUS pandemic
BioXone

BioXone

rethinking future

June 5, 2026
  • About
  • BiotechTodayNews
    • IndiaWeekly Biotech News of India
    • WorldWeekly Biotech News of The World
  • DNA-TalesArticles
    • BiotechnopediaInteresting articles written by BioXone members and associates.
    • Scientists’ CornerArticles from the pioneers of Biotechnology.
    • Cellular CommunicationInterview of greatest researchers’ in the field.
  • Myth-LysisFact Check
  • Signalling PathwayCareer related updates
    • ExaminationsExamination related articles.
    • Job and InternshipJobs and Internship related articles.
  • Courses
  • Contact

Most Viewed This Week

October 17, 2023October 16, 2023

The Corrosion Prediction from the Corrosion Product Performance

1
October 1, 2023September 30, 2023

Nitrogen Resilience in Waterlogged Soybean plants

2
September 28, 2023September 28, 2023

Cell Senescence in Type II Diabetes: Therapeutic Potential

3
September 26, 2023September 25, 2023

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

4
September 25, 2023September 25, 2023

AI Literacy in Early Childhood Education: Challenges and Opportunities

5
September 22, 2023October 1, 2023

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

6

Search Field

Subscribe Now

  • Home
  • BiotechToday
  • A Challenge to Central Dogma

Understanding the importance of forensic odontology

Alzheimer’s-like dementia due to Covid

A Challenge to Central Dogma
  • BiotechToday
  • World

A Challenge to Central Dogma

BioTech Today June 17, 2021June 17, 2021

Nandini Pharasi, Jaypee Institute of information technology

Thomas Jefferson provided the first evidence that RNA segment can be written back to DNA which is a great challenge to central dogma. Each cell in our body has a specific mechanism that is it undergoes duplication of DNA to form new cells. The enzyme behind this is polymerase, which synthesizes a long change of polymer of nucleic acid and this further assembles into RNA and DNA molecules. In the case of DNA, the template uses base-pairing interactions, which helps adenine to combine with thymine whereas cytosine pairs with guanine. In the case of RNA, guanine is replaced by another nitrogenous base, uracil. RNA messages build by polymerase enzymes that is like copying notes from the book of DNA master recipes. Hypothetically it was considered that polymerases work only in one direction that is from DNA to DNA or from DNA to RNA.

What is the central dogma of life?

The central dogma is a process that gives us information about the genetic flow or how the information is passed from one generation to the next. It is the main mechanism behind the conversion of DNA to RNA and then from RNA to protein. The cell undergoes replication (DNAàDNA) followed by transcription (DNAà RNA) and then further translation (RNAà proteins). In replication DNA polymerase replicates the DNA which further produces copies of DNA that goes to the next step of transcription with the help of RNA polymerase. In transcription, DNA is converted into RNA and that RNA goes to translation, which is the process by which RNA is converted into proteins with the help of ribosomes. Until recently, this flow was considered to be the only way of transfer of information because it prevents messages from being rewritten back from RNA to DNA.

The challenge to central dogma:

Researches now raise many questions about this widely accepted theory, which poses a huge challenge to central dogma. This finding will help us in the future to open many doors towards other researches which will help to understand the mechanism of conversion of RNA messages to DNA in a better way. RNA messages might be used as templates for rewriting genomic DNA. A team of Dr. Pomerantz’s provided interesting results by scrutinizing polymerase θ – an exceptional polymerase.

Polymerase θ belongs to a family of higher eukaryotes, evolved from an enzyme named Pol1 which gives it a unique property of forming helicase fusion protein. Pol θ represents a promising cancer drug target. This means it is highly expressed in oncogenes that cause cancer. Pol θ is highly error-prone. It can acquire mutation, which is the reason behind the inactive proofreading domain. Polθ repairs DNA but has no control over mutations that might occur during proofreading. The study hypothesized that Polθ has RNA-dependent DNA synthesis activity.

The researchers tested polymerase theta by experimenting on HIV (Human Immunodeficiency Virus) through reverse transcriptase which is possibly the best study for this discovery. This study showed that polymerase theta is capable of converting RNA messages into DNA.

It is better than duplicating DNA to DNA because it shows fewer errors in RNA template, it works more efficiently in reverse transcriptase while using polymerase theta used by RNA template to rewrite DNA. The collaborated group used X-Ray Crystallography to be able to change the shape of RNA into a more bulky structure, which was a triumph unique achievement among all polymerases. Researchers say that the main function of polymerase theta is to act as reverse transcriptase. In healthy cells, these polymerases will be mediated by RNA that helps DNA repair and in abnormal cells such as cancerous cells, this polymerase theta is found to be expressed highly.

Also read: Understanding the importance of forensic odontology

Reference:

  1. Chandramouly, G., Zhao, J., McDevitt, S., Rusanov, T., Hoang, T., Borisonnik, N., Treddinick, T., Lopezcolorado, F. W., Kent, T., Siddique, L. A., Mallon, J., Huhn, J., Shoda, Z., Kashkina, E., Brambati, A., Stark, J. M., Chen, X. S., & Pomerantz, R. T. (2021). Polθ reverse transcribes RNA and promotes RNA-templated DNA repair. Science Advances, 7(24), eabf1771. https://doi.org/10.1126/sciadv.abf1771
  • The Corrosion Prediction from the Corrosion Product Performance
  • Nitrogen Resilience in Waterlogged Soybean plants
  • Cell Senescence in Type II Diabetes: Therapeutic Potential
  • Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP
  • AI Literacy in Early Childhood Education: Challenges and Opportunities

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Related

Tagged Central dogma central dogma of life DNA as genetic material DNA double helix DNA full form DNA ligase DNA replication DNA structure DNA timeline protein synthesis replication the discovery of DNA and RNA transcription Translation

3 thoughts on “A Challenge to Central Dogma”

  1. Sanidhi says:
    June 17, 2021 at 6:45 am

    I really liked this article, it’s a great discovery and opened my door’s

    Reply
    1. Nandini Pharasi says:
      June 18, 2021 at 5:49 pm

      Thankyou sanidhi for your kind words

      Reply
  2. Pingback: Sound-light pulse in 2D materials for the first time - BioXone

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Next Post
  • BiotechToday
  • World

Alzheimer’s-like dementia due to Covid

BioTech Today June 17, 2021

Souradip Mallick, National Institute of Technology, Rourkela In the last two decades, various coronavirus diseases have become a major public health issue, starting with the SARS-CoV pandemic in 2002 through 2003, then the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in 2012, and current the COVID-19 pandemic. In all the cases, it has been reported […]

Related Post

  • BiotechToday
  • World

VV116 vs. Nirmatrelvir-Ritonavir Against COVID-19

DNA tales April 23, 2023April 23, 2023

Tholkappian R, NIT Durgapur Nirmatrelvir is an oral inhibitor of the SARS-CoV-2’s, 3-chymotrypsin–like cysteine protease, while VV116 is a deuterated remdesivir hydro-bromide with potent activity against SARS-CoV-2. Nirmatrelvir-ritonavir was used to treat COVID-19 of low to moderate severity. However, its production could not meet the global supply demands. VV116 is one such oral analog of […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Monoclonal antibodies against SARS-CoV-2 spike protein

bioxone October 6, 2020October 6, 2020

Prama Ghosh, Amity University Kolkata The alarming hypothesis that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic to be around for several years calls for rapid and successful therapies. Though anti-SARS-CoV-2 spike monoclonal antibodies originated from mice have shown robust performance in various immunoassays including western blotting, ELISA, immunofluorescence, and immunoprecipitation, there is still a […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X
  • BiotechToday
  • World

Heart failure in the case of post-menopausal women

bioxone November 30, 2020November 30, 2020

Parnad Basu, Amity University Kolkata Doctors have been saying for a very long time that there is no substitution to exercise if you want to live a healthy life. Often than not we have seen that those who don’t ‘move’ from a place for a very long time are prone to diseases like a heart […]

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

Breaking News

The Corrosion Prediction from the Corrosion Product Performance

Nitrogen Resilience in Waterlogged Soybean plants

Cell Senescence in Type II Diabetes: Therapeutic Potential

Transgene-Free Canker-Resistant Citrus sinensis with Cas12/RNP

AI Literacy in Early Childhood Education: Challenges and Opportunities

Sustainable Methanol Vapor Sensor Made with Molecularly Imprinted Polymer

Exogenous Klotho as a Cognition Booster in Aging Primates

Terms and Conditions
Shipping and Delivery Policy
Cancellation and Refund Policy
Contact Us
Privacy Policy